Pacer Advisors
EDIT icon

Pacer Advisors’s Editas Medicine EDIT Stock Holding History

Pacer Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,222
Closed -$5.71K – 2602
2024
Q2 		$5.71K Sell
1,222
-2,526
-67% -$14.2K ﹤0.01% 3623
2024
Q1 		$27.8K Buy
+3,748
New +$31.1K ﹤0.01% 3377
2021
Q2 		– Sell
-1,682
Closed -$71K – 1450
2021
Q1 		$71K Sell
1,682
-450
-21% -$25.6K ﹤0.01% 1367
2020
Q4 		$149K Sell
2,132
-1,552
-42% -$63.8K ﹤0.01% 1284
2020
Q3 		$103K Buy
+3,684
New +$120K ﹤0.01% 1245
2018
Q4 		– Sell
-7,434
Closed -$237K – 692
2018
Q3 		$237K Buy
+7,434
New +$240K 0.01% 995
2018
Q1 		– Sell
-1,825
Closed -$56K – 1063
2017
Q4 		$56K Buy
+1,825
New +$46K ﹤0.01% 999

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pacer Advisors's EDIT Position: Q3 2024 in Review

Pacer Advisors sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 1,222 shares — an estimated $5.71K sold.

Pacer Advisors first reported a position in EDIT in Q4 2017 and held it in 7 quarters. The position peaked at $237K in Q3 2018. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.

  • Pacer Advisors reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 1,222 Editas Medicine shares in Q3 2024, an estimated $5.71K.
  • Pacer Advisors first reported a position in Editas Medicine in Q4 2017 and held it in 7 quarters.
  • Pacer Advisors's Editas Medicine position peaked at $237K in Q3 2018.
  • 229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.